Standardization, regulation, quality assurance and emerging technologies in hemostasis: issues, controversies, benefits, and limitations.
about
D-Dimer for venous thromboembolism diagnosis: 20 years later.External quality assurance as a revalidation method for pathologists in pediatric histopathology: Comparison of four international programsLaboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays.Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
P2860
Standardization, regulation, quality assurance and emerging technologies in hemostasis: issues, controversies, benefits, and limitations.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Standardization, regulation, q ...... es, benefits, and limitations.
@en
type
label
Standardization, regulation, q ...... es, benefits, and limitations.
@en
prefLabel
Standardization, regulation, q ...... es, benefits, and limitations.
@en
P356
P1476
Standardization, regulation, q ...... es, benefits, and limitations.
@en
P304
P356
10.1055/S-2007-971816
P577
2007-04-01T00:00:00Z